Diagnostic Efficacy of T-SPOT.TB for Active Tuberculosis in Adult: A Retrospective Study

References

• WHO. Global Tuberculosis Report. WHO; 2021.
   Google Scholar
• Mahairas GG, Sabo PJ, Hickey MJ, et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol. 1996;178(5):1274–1282. doi:10.1128/jb.178.5.1274-1282.1996
   PubMed Web of Science ®Google Scholar
• Sørensen AL, Nagai S, Houen G, et al. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun. 1995;63(5):1710–1717. doi:10.1128/iai.63.5.1710-1717.1995
   Web of Science ®Google Scholar
• Pai M, Riley LW, Colford JM. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004;4(12):761–776. doi:10.1016/S1473-3099(04)01206-X
   PubMed Web of Science ®Google Scholar
• Januarie KC, Uhuo OV, Iwuoha E, et al. Recent advances in the detection of interferon-gamma as a TB biomarker. Anal Bioanal Chem. 2021;414(2):907–921. doi:10.1007/s00216-021-03702-z
   Web of Science ®Google Scholar
• Dheda K, van Zyl Smit R, Badri M, et al. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med. 2009;15(3):188–200. doi:10.1097/MCP.0b013e32832a0adc
   Web of Science ®Google Scholar
• Lu P, Chen X, Zhu LM, et al. Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis: a Systematic Review and Meta-analysis. Lung. 2016;194(3):447–458. doi:10.1007/s00408-016-9872-5
   Web of Science ®Google Scholar
• Kahwati LC, Feltner C, Halpern M, et al. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016;316(9):970–983. doi:10.1001/jama.2016.10357
   PubMed Web of Science ®Google Scholar
• Janssens JP, Roux-Lombard P, Perneger T, et al. Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis. Eur Respir J. 2007;30(4):722–728. doi:10.1183/09031936.00028507
   PubMed Web of Science ®Google Scholar
• Ai L, Feng P, Chen D, et al. Clinical value of interferon-γ release assay in the diagnosis of active tuberculosis. Exp Ther Med. 2019;18(2):1253–1257. doi:10.3892/etm.2019.7696
   PubMed Web of Science ®Google Scholar
• Haas MK, Belknap RW. Diagnostic Tests for Latent Tuberculosis Infection. Clin Chest Med. 2019;40(4):829–837. doi:10.1016/j.ccm.2019.07.007
   PubMed Web of Science ®Google Scholar
• Zhou G, Luo Q, Luo S, et al. Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2020;20(12):1457–1469. doi:10.1016/S1473-3099(20)30276-0
   PubMed Web of Science ®Google Scholar
• Lu P, Chen X, Zhu LM, et al. Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis: a Systematic Review and Meta-analysis. Lung. 2016;194(3):447–458.
   Web of Science ®Google Scholar
• Zhang L, Yang Z, Bao X, et al. Comparison of diagnostic accuracy of QuantiFERON-TB Gold Plus and T-SPOT.TB in the diagnosis of active tuberculosis in febrile patients. J Evid Based Med. 2022;15(2):97–105. doi:10.1111/jebm.12477
   Google Scholar
• Kahwati LC, Feltner C, Halpern M, et al. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016;316(9):970–983.
   PubMed Web of Science ®Google Scholar
• Boyd AE, Ashcroft A, Lipman M, et al. Limited added value of T-SPOT.TB blood test in diagnosing active TB: a prospective Bayesian analysis. J Infect. 2011;62(6):456–461. doi:10.1016/j.jinf.2011.04.003
   Web of Science ®Google Scholar
• Gao L, Lu W, Bai L, et al. Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis. 2015;15(3):310–319. doi:10.1016/S1473-3099(14)71085-0
   PubMed Web of Science ®Google Scholar
• Ma Y, Li R, Shen J, et al. Clinical effect of T-SPOT.TB test for the diagnosis of tuberculosis. BMC Infect Dis. 2019;19(1):993. doi:10.1186/s12879-019-4597-8
   Web of Science ®Google Scholar
• Tavares SM, Junior Wde L, Lopes ESMR. Normal lymphocyte immunophenotype in an elderly population. Rev Bras Hematol Hemoter. 2014;36(3):180–183. doi:10.1016/j.bjhh.2014.03.021
   Google Scholar
• Kamiya H, Ikushima S, Kondo K, et al. Diagnostic performance of interferon-gamma release assays in elderly populations in comparison with younger populations. J Infect Chemother. 2013;19(2):217–222. doi:10.1007/s10156-012-0480-x
   Web of Science ®Google Scholar
• Yang C, Zhang S, Yao L, et al. Evaluation of risk factors for false-negative results with an antigen-specific peripheral blood-based quantitative T cell assay (T-SPOT((R)). TB) in the diagnosis of active tuberculosis: a large-scale retrospective study in China. J Int Med Res. 2018;46(5):1815–1825. doi:10.1177/0300060518757381
   Web of Science ®Google Scholar
• Shangguan Y, Fang H, Wang S, et al. Risk factors for negative T-SPOT.TB assay results in patients with confirmed active tuberculosis: a retrospective study. J Infect Dev Ctries. 2020;14(11):1288–1295. doi:10.3855/jidc.12063
   Web of Science ®Google Scholar
• Pan L, Jia H, Liu F, et al. Risk factors for false-negative T-SPOT.TB assay results in patients with pulmonary and extra-pulmonary TB. J Infect. 2015;70(4):367–380. doi:10.1016/j.jinf.2014.12.018
   PubMed Web of Science ®Google Scholar
• Mori T, Harada N, Higuchi K, et al. Waning of the specific interferon-gamma response after years of tuberculosis infection. Int J Tuberc Lung Dis. 2007;11(9):1021–1025.
   PubMed Web of Science ®Google Scholar
• Bai X, Stitzel JA, Bai A, et al. Nicotine Impairs Macrophage Control of Mycobacterium tuberculosis. Am J Respir Cell Mol Biol. 2017;57(3):324–333. doi:10.1165/rcmb.2016-0270OC
   PubMed Web of Science ®Google Scholar
• Feng Y, Kong Y, Barnes PF, et al. Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infect Immun. 2011;79(1):229–237. doi:10.1128/IAI.00709-10
   PubMed Web of Science ®Google Scholar
• O’Leary SM, Coleman MM, Chew WM, et al. Cigarette smoking impairs human pulmonary immunity to Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2014;190(12):1430–1436. doi:10.1164/rccm.201407-1385OC
   PubMed Web of Science ®Google Scholar
• Yamashiro S, Kawakami K, Uezu K, et al. Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol. 2005;139(1):57–64. doi:10.1111/j.1365-2249.2005.02677.x
   PubMed Web of Science ®Google Scholar
• Miramontes R, Hill AN, Yelk Woodruff RS, et al. Tuberculosis Infection in the United States: prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012. PLoS One. 2015;10(11):e0140881. doi:10.1371/journal.pone.0140881
   PubMed Web of Science ®Google Scholar
• Hochberg NS, Horsburgh CR. Prevention of tuberculosis in older adults in the United States: obstacles and opportunities. Clin Infect Dis. 2013;56(9):1240–1247. doi:10.1093/cid/cit027
   PubMed Web of Science ®Google Scholar
• Huang HL, Huang WC, Lin KD, et al. Completion Rate and Safety of Programmatic Screening and Treatment for Latent Tuberculosis Infection in Elderly Patients With Poorly Controlled Diabetic Mellitus: a Prospective Multicenter Study. Clin Infect Dis. 2021;73(6):e1252–e1260. doi:10.1093/cid/ciab209
   Web of Science ®Google Scholar
• Zhu C, Liu Z, Li Z, et al. The performance and limitation of T-SPOT.TB for the diagnosis of TB in a high prevalence setting. J Thorac Dis. 2014;6(6):713–719. doi:10.3978/j.issn.2072-1439.2014.04.38
   Web of Science ®Google Scholar